Navigation Links
Global warming linked to European viral epidemic
Date:1/15/2009

An epidemic of the viral disease nephropathia epidemica (NE) has been linked to increases in the vole population caused by hotter summers, milder winters and increased seedcrop production by broadleaf trees. Research published in BioMed Central's open access International Journal of Health Geographics links outbreaks of this rodent-borne disease to known effects of global warming.

Dr Jan Clement from the Department of Microbiology & Immunology at Belgium's Rega Institute (University of Leuven) worked with a team of medical researchers and bioscience-engineers to investigate outbreaks of NE in Belgium. Dr. Clement founded the Belgian Hantavirus Reference Centre in 1985, and noted that of the 2,200 cases since then, 828 (37.6%) occurred in just the last three years, 2005-2007. The epidemic has been shown to extend to neighboring countries such as France, Germany, The Netherlands, and Luxembourg. He said, "This animal-borne disease, scarcely known before 1990, has been increasing in incidence in Belgium with a cyclic pattern, reaching epidemic proportions since 2005. The fact that the growing combined effect of hotter summer and autumn seasons is matched by the growth of NE in recent years means this epidemic can be considered an effect of global warming".

NE is caused by infection with Puumala virus (PUUV), which is spread by the bank vole, a rodent common throughout most of Europe. The authors believe that warmer weather causes increases in the amount of 'mast', plant seeds from oak and beech trees, that forms the voles' staple diet. This plethora of food results in increases in the vole population and warm summers raise the chances that people will visit the forests where the voles live. According to Clement, "Since 1993, each NE peak has been preceded by increased autumnal mast formation the year before, resulting in yearly NE numbers significantly higher than those during the mast years themselves".

PUUV is a hantavirus, a group of viruses known to cause hemorrhagic fevers (fevers combined with bleeding disorders). NE is a relatively mild hemorrhagic fever that causes flu-like symptoms often with renal complications, sometimes also with pulmonary problems, needing Intensive Care treatment, such as acute dialysis and/or mechanical ventilation. In some rare cases it can, moreover, cause the shock with internal haemorrhaging and death for which these infections are infamous. Clement said, "In 1997, more than 9,000 people in the Russian republic of Bashkortostan contracted the disease, of which 34 cases were fatal".


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-707-94804
BioMed Central
Source:Eurekalert

Related biology news :

1. Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling
2. Lifecycles of tropical cyclones predicted in global computer model
3. USC researchers head global effort to study genetic risks that contribute to psychiatric diseases
4. Using water to understand human society, from the industrial revolution to global trade
5. Light pollution offers new global measure of coral reef health
6. Global warming is changing organic matter in soil
7. Issues at intersection of climate change and health impact global well-being
8. UI researchers help to improve carbon measurements in global climate studies
9. Global warming link to amphibian declines in doubt
10. Less than one month to opening of world’s largest global congress on osteoporosis
11. Global warming predicted to hasten carbon release from peat bogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Tenn. , Feb. 24, 2017 ... ("Provectus" or the "Company"), a clinical-stage oncology and ... regarding the deadline to participate in its previously ... units, consisting of shares of common stock and ... and holders of listed warrants. ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... host a Key Opinion Leader event to highlight new ... and poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology ... event will be held in-person and via live webcast ... 9:00 AM PST at the Lotte New York Palace ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
Breaking Biology Technology: